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1. Introduction 
In 1953 Kaplan and co-workers [l] discovered that 
extracts of Pseudomonas fluorescens catalyzed the reduc- 
tion of NAD+ by NADPH according to the reversal of the 
reaction 
NADP+ + NADH = NADPH + NAD+ (11 
* Corresponding author. Fax: + 46 3 1 77339 10. 
Somewhat later the same year this group demonstrated that 
a similar activity was present in animal tissue [2]. It then 
took 10 years before Danielsson and Emster showed that 
transhydrogenase was linked to the energy-transfer system 
of the respiratory chain, i.e., utilizing the same intermedi- 
ate as the ATP synthase [3]. The existence of a so-called 
energy-linked transhydrogenase, which drives the reaction 
from left to right at an enhanced rate and a concomitantly 
shifted apparent equilibrium towards NADPH formation, 
had indeed been proposed earlier on the basis of the 
difference in redox levels of NAD and NADP in intact 
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mitochondria [4]. This discovery by Danielsson and Em- 
ster [3] triggered an intense research on the mode of 
interaction of transhydrogenase with the energy-transfer 
system. Major recent advances in transhydrogenase re- 
search have been the purification [5,6] and reconstitution 
of beef heart transhydrogenase [5,7], the demonstration 
that beef heart transhydrogenase is a proton pump [7], 
reconstitution of ATP and bacteriorhodopsin-driven trans- 
hydrogenase [8,9], and the cloning and sequencing of the 
DNA/cDNA of E. coli [ IO,1 I] and beef heart transhydro- 
genases [ 121. Several reviews have covered these aspects 
as well as the kinetics, regulation and structure-function 
relations of different transhydrogenases up to about 
1990/91 [13-191. 
A separate previous review has been devoted to possi- 
ble physiological roles of transhydrogenase in mammals 
[20]. In a more recent review an additional role of trans- 
hydrogenase was proposed in which the enzyme is sug- 
gested to regulate the flux of substrates through the NADP 
and NAD-linked isocitrate dehydrogenases [2 11. However, 
the physiological role(s) of transhydrogenases remains an 
open question. 
genase. An overexpression of this enzyme of about 70-fold 
allows essentially unlimited amounts of pure enzyme to be 
produced. To date, no other transhydrogenase(s) has been 
expressed in any host system. However, the genes of six 
H+-TH’s have now been cloned and sequenced, which 
allow a reliable determination of conserved regions and 
domains of importance for NAD(P)-binding and proton 
pumping. Not all of these genes have as yet been shown to 
code for a H+-TH, although this is very likely. Neverthe- 
less, based on amino acid sequences and similarities with 
other enzymes, three-dimensional structures of functional 
domains can now be predicted and tested by, for example, 
mutagenesis. Such functional domains are also being pro- 
duced by expression in E. coli host cells and their struc- 
tures are being examined by NMR. 
The transhydrogenase reaction catalyzed by proton- 
pumping transhydrogenases of the so-called AB-type (de- 
noted H+-TH in the following text), in contrast to the 
BB-transhydrogenases which are soluble and different with 
regard to a number of properties, may be described as 
nHZ”, + NADP+ + NADH + nH:, + NADPH + NAD+ 
(2) 
where ‘n’ denotes the number of protons pumped across 
the membrane, and ‘in’ and ‘out’ the matrix and intermem- 
brane space, respectively, of mitochondria, or cytoplasm 
and periplasmic space, respectively, of bacteria. The reac- 
tion from left to right is the predominant direction of the 
reaction in the intact mitochondrion/bacterial cell, driven 
by the existing electrochemical proton potential, Ap. It 
may be safely concluded that no other protein(s) is re- 
quired for the Ap-driven H+-TH to function, which has 
been demonstrated by the co-reconstitution of H+-TH with 
either ATPase or bacteriorhodopsin as Ap-generators [8,9]. 
H+-TH’s offer a number of advantages as model system 
for studies of the mechanism of proton pumps, e.g., they 
are composed of only l-3 polypeptides and therefore 
represent a relatively simple structure, they are relatively 
hydrophilic for a membrane protein, and are easily purified 
and reconstituted in liposomes with or without other pro- 
ton pumps. In addition, the reaction can be followed 
directly spectrophotometrically by using various substrate 
analogues, and there are no scalar protons consumed or 
generated in the reaction which complicate measurements 
of vectorial protons. 
It is increasingly evident that the H’-TH’s characterized 
so far represent a unique set of enzymes, in which two 
redox sites interact directly to generate a redox potential 
difference sufficient to drive proton pumping. The finding 
that especially the hydrophilic N-terminal domain of H+- 
TH (the a-subunit in E. coli transhydrogenase) shows a 
high degree of amino acid sequence identity with alanine 
dehydrogenase [22,23] as well as other dehydrogenases 
[24], suggests that H+-TH’s have evolved from dehydro- 
genases/reductases rather than from, for instance, ATP- 
ases or other proton pumps driven by electron transport. 
This evolutionary pathway is supported by the proposed 
proton-pumping/conducting structure of HC-TH involving 
a single histidine which has not been demonstrated previ- 
ously in other pumps (cf. Sections 8 and 9). Obviously, 
this raises the question whether Hf-TH’s will remain a 
unique class of proton pumps or whether they will turn out 
to be representatives of pumps of hitherto unknown struc- 
tures. A very interesting development in this context is that 
cDNA-derived amino acid sequences homologous to those 
of the major H+-TH’s have been found in the protozoan 
parasites Eimeriu tenella, Eimeria acerculina and Entu- 
moeba histolytica [25-271, which also show sequence ho- 
mology to proteins involved in sugar transport [25]. 
The present review will emphasize structure-function 
relations of H+-TH at the molecular level and also in- 
cludes aspects related to properties and expression of 
H+-TH genes. These areas of H+-TH research have been 
essentially lacking in previous reviews and the special 
emphasis of this review is therefore justified by the recent 
developments in molecular biology-related approaches used 
in investigations of H+-TH’s and the mechanism of proton 
pumping catalyzed by these enzymes. 
2. Proton-pumping transhydrogenases 
Site-directed mutagenesis is an additional and attractive Like most proton pumps, H+-TH can either use or 
possibility to study structure-function relations of trans- generate a Ap depending on the direction of the reaction 
hydrogenase, so far using primarily the E. coli transhydro- catalyzed. The direction from left to right in reaction 2 (the 
T. Olausson et al./Biochimica et Biophysics Acta 1231 (lYY51 I-IY 3 
Bovine 
NAD(H)-binding Transmembrane 
domain domain 
domain 
1 432 639 1043 
Tenella 
Cd a404 a510 61 6260 6462 
E-coli 
AA1 AA364 A01 Bl 6260 9464 
R. rubrum 
AB25 A8139 
Fig. 1. A comparison of the NAD(H)-binding, transmembrane and 
NADP(H)-binding domains of bovine, Tenella, E. coli and R. rubrum 
H +-TH. 
‘forward’ reaction) is slow in the absence of Ap but is 
nevertheless coupled to proton pumping. In the presence of 
a Ap generated by any other proton pump(s), the rate of 
this reaction is stimulated 5--IO-times and the 
product/substrate ratio, i.e., [NADPH][NAD + ]/ 
[NADH][NADP+], is increased by a factor of up to 500 
(the so-called ‘energy-linked’ reaction). However, this lat- 
ter ratio is normally not reached in the intact mitochon- 
drion/bacterial cell because of a number of competing 
reactions which will reoxidize NADPH and rereduce 
NAD+. The right to left direction of reaction 2 (the 
‘reverse’ reaction) is faster and its maximal velocity ap- 
proaches that of the Ap-driven forward reaction. 
Despite the fact that H+-TH is an integral and ion-trans- 
locating membrane protein, it is surprisingly hydrophilic, 
with an approximate molecular mass of 100-l 10 kDa for 
the monomeric form or minimal assembly of subunits, of 
which only approximately 35% is located in a hydrophobic 
membrane-bound domain. As judged from the bovine H+- 
PERIPLASM 
2H+ 
t 
Dehydro- 
genases 
TH which has two separate binding sites for NAD(H) and 
NADP(H) [28], respectively, all H+-TH’s have their sub- 
strate-binding sites located in two hydrophilic domains of 
the enzyme, separated by a hydrophobic domain. These 
binding sites are exposed to the matrix in mitochondria 
and cytoplasm in bacteria. Presumably, the hydrophobic 
domain contains the proton-conducting structure, which is 
assumed to consist of a helical bundle containing lo- 12 
predicted transmembrane cy-helices (cf. Section 6). Only a 
minor part of the hydrophobic domain, approximately 5%, 
is exposed on the cytosolic side in mitochondria (peri- 
plasmic space in bacteria). 
The three domains of all H+-TH’s the amino acid 
sequences of which have been deduced from their 
cDNA/DNA, i.e., the bovine [12], E. coli [I I], Rhodo- 
spirillum rubrum [29,30], Eimeria acervulina [25], Eime- 
ria tenella [26] and Entamoeba histolytica [27] enzymes, 
are shown in Fig. 1, in which the parasite H+-TH’s are 
represented by the Tenella enzyme. The CY 1 + CY 2-subunits 
of the Rhodospirillum rubrum enzyme correspond essen- 
tially to the a-subunit of the E. coli enzyme [29,30] (in the 
text below the gene products PntAA. PntAB and PntB of 
the R. rubrum enzyme will be referred to as CY 1, a 2 and 
/3). Human brain H+-TH has been identified and shown to 
be homologous to the bovine enzyme [3 1 I and its gene was 
shown to be located to chromosome 5 [32], but the whole 
gene has not yet been sequenced. Interestingly, the parasite 
enzymes differ with regard to the intramolecular distribu- 
tion of the three domains. Whereas the three non-parasite 
H+-TH’s are transcribed from the N-terminal to the C- 
terminal of the monomer, or the N-terminal to the C-termi- 
nal of the a-subunit followed by the N-terminal to the 
C-terminal of the P-subunit, etc., the three parasite Hf- 
TH’s start with the N-terminal of a sequence which is 
2H+ 2H+ 
t t 
H+ 3H+ 
I 
CYTOPLASM F4-l Pi +ADP 3H+ ATP 
Fig. 2. The major proton pumps of the plasma membrane of E. coli H+-TH is shown as the active dimer form. However, the remaining 
pumps/complexes contributing to a Ap are not necessarily shown as their active forms. 
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homologous with the /3-subunit of the non-parasite H’- 
TH’s. This has implications for the assembly of H+-TH 
discussed in Section 7. 
As exemplified with the E. coli HI-TH, Fig. 2 shows 
the topology of this enzyme in relation to the electron 
transport system and ATPase. Presumably, the topology of 
the bovine [12,19], Rhodospirillum ruhrum [29,30] and 
Rhodobacter cupsulatus [22] enzymes are similar to that of 
the E. coli enzyme. Little is known about the topology of 
the Eimeria transhydrogenases, but apart from the re- 
versed order of transcription there is nothing that indicates 
that their topology would differ from the majority of the 
H+-TH’s. Since the parasite of the Entumoebu histolyticu 
type does not have mitochondria [27] the localization of 
H+-TH in this organism is presently unclear. 
Table 1 summarizes some key properties of Hf-TH’s 
from different sources. The cloning and sequencing of the 
E. coli and bovine H+-TH genes, and recently also the 
gene for the Rhodospirillum rubrum enzyme, have led to a 
considerable advancement in the characterization of these 
enzymes. Thus, the subunit compositions of the active 
enzymes have been elucidated in all three cases except for 
the R. rubrum enzyme which, however, may be assumed 
to be ~rl~cr2~&, where a 1 is loosely and reversibly 
bound to the remainder of the complex. Both the bovine 
and E. coli enzymes have a k,,, value of about 50- 100 
SC’, a value range which probably is typical for most 
H+-TH’s. The parasitic enzymes are not included in Table 
1 mainly because their biochemical properties have not yet 
been sufficiently characterized. 
As shown in Table 1, the value of H+/H-,or ‘12’ in Eq. 
(2), has been determined to be I .O in the case of the bovine 
H+-TH and 0.5 in the case of the Rhodobucter capsulutus 
enzyme. It is unlikely that the true ‘n’ values for the two 
enzymes are different, which means that either of the two 
determinations. or both, are erroneous. Indeed, the meth- 
ods used to arrive at the values were different. The bovine 
value was determined independently by Earl and Fisher [7] 
and by Rydstrijm and co-workers [8,33], in both cases 
employing pure enzyme reconstituted in phospholipid vesi- 
cles. Jackson and co-workers [40] used intact membranes 
from Rhodobacter cupsulutus and an indirect method based 
Table I 
Properties of H+-TH’s from different sources 
on absorbance changes of endogenous carotenoid pig- 
ments. Recently, Jackson and co-workers (T. Bizouam, 
L.A. Sazanov and J.B. Jackson, unpublished data), using a 
pH-indicator dye (Cresol red) to monitor proton transloca- 
tion on a rapid time-scale, measured values of the H+/H- 
in the region of 1.0 with chromatophore membranes iso- 
lated from an over-expressing strain of Rhodospirillum 
rubrum and with liposome membranes inlaid with mito- 
chondrial Hf-TH. Even though it is generally easier for 
obvious reasons to obtain too low a ratio, a recent demon- 
stration that movements of protons along the membrane 
surface are considerably faster than the equilibration be- 
tween membrane surface protons and the bulk solute [41] 
may indicate a source of underestimation of the H+/H- 
ratio in complex systems. In fact, this is the first indepen- 
dent support for a localized interaction between proton 
pumps originally suggested by Ernster and coworkers on 
the basis of the energetics of the ATP synthase and H+-TH 
systems [42.43]. However, there is a large and increasing 
body of evidence in favour of a delocalized interaction of 
H+-TH with other proton pumps (cf. [9,16- 19,44,45]). 
As is evident from Fig. 2, H+-TH competes with, for 
example, the ATP synthase for the available Ap generated 
by electron transport when the direction of the transhydro- 
genase reaction is that of NADPH generation. The trans- 
hydrogenase reaction may also be reversed so as to gener- 
ate, for instance, ATP, but only at a very high 
[NADPH][NAD+]/[NADH][NADP+] ratio [46]. Despite 
repeated attempts, reconstituted transhydrogenase-ATPase 
vesicles have not been found to generate ATP under 
similar conditions, possibly because of the presence of 
uncoupled/excess ATPase in these preparations (G. Eytan 
and J. Rydstriim. unpublished data). In this context, the 
number of protons being pumped/translocated in the 
transhydrogenase reaction is of course essential [20,21]. If 
the value is 0.5, Hf-TH is a relatively poor pump which is 
locked into a state of NADPH generation. However, exper- 
imentally it has been shown repeatedly that H+-TH never- 
theless is an efficient consumer of Ap, much more effi- 
cient than, for instance, ATP synthase when the two 
systems compete for the same Ap [ 14,47,48]. If ‘n’ equals 
1 .O, a more potent pump is obtained which may contribute 
Source Subunits Active form kc,,, (SC’) H+/H- Refs 
Bovine heart 
E. coli 
Rhodosp. ruhrum 
Rhodob. caps. 
Mol. mass (kDa) 
109 
:4 
al a2 
40 15 
53 
P 
48 
P 
48 
48 
dimer 
a? P? 
(ul,(Y2, Pz? 
n.d. 
60 
IO0 
n.d. 
n.d. 
I .o 
n.d. 
n.d. 
0.5 
[7,8,12,33-361 
[10,37,381 
L29.301 
139,401 
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substantially to the redox level of NADP, as well as 
generate a Ap under conditions when the activities of 
other proton pumps are decreased. This is of course pro- 
vided that the [NADPH][NAD+]/[NADH][NADP+] ratio 
is sufficiently high, since this ratio is the only input of free 
energy. However, under normal cellular conditions it is 
assumed that H+-TH is a device that basically converts 
NADH into NADPH at the expense of a Ap. The recent 
interesting suggestion by Sazanov and Jackson [21] that 
H+-TH regulates the flow of substrates mainly through the 
NAD+ and NADP+-dependent isocitrate dehydrogenases, 
has provided another theoretical function which may be 
subjected to an experimental test. One observation that 
apparently does not fit the latter suggestion is that the 
Ap-driven H’-TH is rapidly saturated at increasing Ap 
and, unless NADPH is rapidly oxidized by other systems, 
probably relatively inactive at, for example, State 4 due to 
product inhibition [20]. Indeed, this may be the reason why 
it has been difficult in the past to estimate transhydro- 
genase activity in intact mitochondria using redox couples 
[43], or bacteria [49]. However, as indeed pointed out by 
Hoek and Rydstriim [20] and by Sazanov and Jackson [21], 
the enzyme may well have different functions depending 
on the type of cell/organism in which it is located. An 
interesting method to investigate the role of H+-TH in 
mammals is that of gene knock-out, which is presently 
being pursued in our laboratory. The role of H+-TH in 
parasites, especially the mitochondria-deficient Entamoeba 
histol~~tica, also poses a challenge and may indeed involve 
a separate function. 
3. Cloning, expression and mutagenesis 
The first gene, encoding E. coli H+-TH, was isolated 
by Clarke and Bragg [lo]. They grew each of the 2112 
clones in the Clarke and Carbon colony bank and screened 
for elevated levels of H+-TH activity. Three such clones 
were identified, subcloned into pUC13 and cut down to the 
smallest possible fragment expressing H+-TH by use of 
restriction enzymes and exonuclease BAL31. The final 
construct, pDC21, contains the EcTH gene inserted into 
the SstI-H&II sites of pUC13 and overexpresses, under 
control of the 1acZ promoter, H+-TH activity 70-fold in 
the inner membrane of E. coli. The EcTH gene was shown 
to be located in the 35.4 min region of the E. coli genome 
previously mapped as the locus for the EcTH gene [SO]. 
Sequencing of the gene and its products, i.e., the a-and 
P-subunits which probably are co-transcribed, proved the 
gene to be coding for E. coli H’-TH [ 111. The EcTH gene 
was also expressed from a pGEM-7Zf(+) vector (also 
1ucZ promoter) at similar levels [5 11. This construct, pSA2, 
and the pDC2l construct have been used extensively for 
site-directed mutagenesis and expression studies as de- 
scribed below. 
Yamaguchi et al. [ 121 isolated two partially overlapping 
cDNA clones (hTH36- 1 and hTH32- 1) encoding bovine 
mitochondrial H+-TH by screening a bovine hgtl0 [ge- 
nomic] cDNA library with two synthetic oligonucleotides 
and a cDNA restriction fragment as probes. Synthetic 
oligonucleotides were designed from the sequences of two 
tryptic fragments of purified bovine mitochondrial HC-TH. 
Both the N-terminal sequence and the presequence were 
determined from sequenced mRNA after reverse transcrip- 
tion [52]. The complete gene encoding bovine mitochon- 
drial H+-TH was constructed by Holmberg et al. [53] from 
the partially overlapping cDNA clones mentioned above. 
The eight missing N-terminal amino acids were added 
together with a consensus ribosome binding site and this 
construct was put under control of the T7 or the 1acZ 
promoter. However, these constructs, pUG04 and pUGO5, 
respectively, failed to express detectable levels of Hf-TH. 
Resequencing of the bovine gene showed that the previ- 
ously reported sequence [ 121 contained three errors; Phe- 
591, Glu-777 and Arg-782, which were identified as Ala- 
59 1, Val-777 and Ala-782, respectively [53]. These changes 
are important, since they eliminate two charged amino-acid 
residues in the predicted transmembrane region [53]. Adams 
et al. [31] reported that the bovine enzyme shows 93% 
identity to an ‘expressed sequence tag’ (86 amino acids) 
from human brain. The method used by Adams et al. [31] 
for rapid characterization of vast numbers of expressed 
genes by partial DNA sequencing will most likely be very 
useful also for cloning of new Hf-TH genes. 
Three H+-TH genes were recently isolated from differ- 
ent protozoan parasites: Eimeriu uceraulinu, Eimeria 
tenellu and Entumoebn histol.yticu. The Eimeriu genes 
were isolated through immunoscreening of hgt 10 and 
Agtll cDNA libraries constructed from mRNA isolated 
from Eimeriu oocysts [25,26]. The Entumoebu histolyticu 
Hf-TH gene was isolated from genomic and cDNA AZAP 
II libraries through hybridization with a radioactive PCR- 
fragment by using primers in the PCR derived from amino 
acid sequences in two highly conserved regions of H+-TH 
[27]. These three H+-TH genes share the somewhat sur- 
prising feature that they are assembled in a /3 j LY order, 
in contrast to the (Y j /3 order of the E. coli, bovine and 
R. rubrum genes (cf. Fig. 1 and Section 7). The Eimeriu 
enzymes show 91% mutual identity, 40% identity to the 
bovine enzyme and 45% identity to the E. coli enzyme. 
The Entumoebu histolyticu enzyme shows 37% overall 
identity with E. tenellu, 46% with E. coli and 42% 
identity with the bovine enzyme. No expression studies on 
the three protozoan H+-TH genes have been reported. 
Cloning and sequencing of H+-TH from Rhodospiril- 
lum rubrum was recently reported by Williams et al. [29] 
and by Yamaguchi and Hatefi [30]. They constructed 
degenerate oligonucleotides from the N-terminal amino 
acid sequences of the soluble part (TH,) and proteolytic 
fragments thereof which were used as PCR primers. This 
PCR-fragment was checked by sequencing and was then 
used for screening a pBR322 library of R. rubrum DNA. 
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Positive clones were restriction enzyme mapped and com- 
pared to a map of the PCR-fragment before they were 
subcloned into pUCl8 and sequenced. Alignment of the R. 
rubrum sequence with the E. coli and bovine sequences 
indicated 50% and 43% identity, respectively. The gene 
corresponding to the a-subunit of E. coli H+-TH proved 
to be split into two parts, the former (PntAA) coding for 
the soluble domain (Y 1 and the latter (PntAB) coding for 
the membrane bound domain (r2 (cf. Fig. 1). The product 
of the third gene ( PntB), the P-subunit, corresponds to the 
P-subunit of E. coli. 
So far, only E. coli transhydrogenase has been reported 
to be overexpressed. However, the Rhodospirillum rubrum 
pntAA H+-TH gene has recently been overexpressed as a 
dimer, is reconstitutively active and has a single unique 
tryptophan (Trp-72) whose very short wavelength emission 
Table 2 
Mutants of E. coli H+-TH and the effects of the mutation on catalytic and proton-pumping activity 
Mutant Cat. act. (8) H+ act. (?k;) Ref. Comment 
wt 
cuY226H 
oY226L 
oY226F 
oY226N 
/3Y3lSH 
py3151 
PY315F 
PY315D 
PY315N 
py315v 
PY315L 
pY431H 
PY43lL 
pY43lF 
pY43lN 
py4311 
PG314E 
pY315F,PY43IF 
aY226F,PY315F,PY431F 
LY D232N 
cy D232E 
LY D232K 
LY D232H 
LY E238Q 
(Y E238Q 
oD232N,oE238Q,oE240Q 
(Y D232H.o E238Q, (Y E240Q 
(Y H450T 
(Y R502S 
P Es2Q 
p E82K 
PH9lS 
PH9lT 
PH9lC 
PHl6lS 
PHl6lT 
PH16lC 
PD213N 
,f3D213H 
/3C26OS 
cxGi72E 
crGl74A 
oGl74S 
cuGl74C 
cuE210V 
oE213K 
olE210Q,(wE213Q 
oE2lOV,cuE213D 
100 
33/5 1 
38 
45 
42 
28 
4 
62 
25 
13 
215 
6 
60/80 
4 
0 
62 
50 
45 
89 
75 
84 
71 
44 
55 
44 
I7 
71 
63 
79 
6 
2 
90 
88 
59 
92 
82 
78 
2 
90 
28 
1.5 
87 
140 
97 
93 
100 
n.d. 
n.d. 
nd. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
0 
n.d. 
nd. 
67 
I IO 
65 
98 
I8 
27 
59 
51 
51 
93 
85 
66 
8 
8 
0 
100 
108 
94 
44 
34 
57 
i 
58 
24 
4 
97 
105 
99 
100 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57 
57, 
57 
57 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
58 
59 
59 
59 
59 
59 
59 
59 
59 
wild type 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADPfH)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
NADP(H)-binding region 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
DCCD-reactive 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
possible H+ pathway 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
NAD(H)-binding region 
Catalytic activity was assayed as reduction of AcPyAD+ by NADPH [57-591 and proton pumping as initial rates of quenching of quinacrine or ACMA 
[57-591. 
is sensitive to binding of NADH, allowing on and off rate 
constants to be determined (Diggle, C., Hutton, M., Jones, 
G.R., Thomas, C.M. and Jackson, J.B., unpublished data). 
Several other attempts to clone H+-TH genes are in 
progress, e.g., the mouse and Klebsiella pneumoniae genes. 
The latter bacterium was recently shown to contain a 
transhydrogenase, most likely an H+-TH but possibly 
Na+-pumping, which cross-reacts with polyclonal antibod- 
ies raised against the bovine H+-TH [54]. 
The effects of substituting various amino acids in E. 
coli H+-TH on the catalytic and proton pumping activities 
are summarized in Table 2. Mutants were produced based 
on PCR methodology or single-stranded phagemid DNA 
[55], all of which were sequenced using the dideoxy chain 
termination method [56]. Most of the mutations in or close 
to the active NAD(H) and NADP(H) sites affected the 
affinity for the substrates [57-591. Some mutations af- 
fected proton pumping. The properties of these mutants are 
described in the following sections. 
4. Sequence homologies with other proteins 
The first H+-TH amino acid sequence published by 
Clarke and Bragg [ 11 I revealed a putative NAD(P)-binding 
sequence but no residues possible involved in proton 
translocation. Naturally, the predictive strength increased 
dramatically when the bovine sequence was subsequently 
published by Hatefi and coworkers [12], since conserved 
Table 3 
Amino acid homologies between the beef heart and E. coli H+-TH and various NAD(P)/flavine-dependent enzymes (from Ref. 1241) 
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residues now could be identified with some certainty. The 
most striking similarities concerned those sequences that 
conceivably are involved in substrate binding, i.e., Pa@ or 
Rossman folds containing the consensus sequence 
GXGXXG [60-621. Four such folds were identified in the 
sequence regions 182-232, 230-280, 880-937 and 994- 
1043 of the bovine enzyme [12,24] and the corresponding 
regions of the E. co/i enzyme [ 11,241. These sequences 
were denoted sequences l-4 (Table 3). Even though the 
substrate-binding sites of the bovine or E. cofi H+-TH at 
this time had not been definitely identified, sequence ho- 
mologies between these regions and those of various dehy- 
drogenases and reductases (Table 3) indicated that the two 
N-terminal (in the a-subunit of the E. coli H+-TH) and 
the two C-terminal (in the P-subunit of the E. coli H+-TH) 
sequences of the bovine enzyme corresponded to possible 
NAD(H) and NADP(H)-binding sites, respectively [24]. 
By using FSBA, an unspecific label for nucleotide-binding 
sites, Hatefi and co-workers [12] attempted to identify the 
substrate-binding sites by exposing purified bovine H+-TH 
to the label in the absence and in the presence of either of 
the substrates NADPH or NADH. The result was that 
sequences 2 (Tyr-245) and 4 (Tyr-1006) were labelled 
[ 121, and these were therefore suggested to form part of the 
NAD(H) and NADP(H)-binding sites, respectively [ 121. 
Unexpectedly, site-specific labelling of the bovine enzyme 
with 8-azido-AMP, constituting part of the substrate 
NAD(H), proved to label sequence 4 assumed to be an 
NADP(H)-site [24]. Because of the lack of reducible (pros- 
ENZYME 
TH-BOV 1 laa182-232) 
TH-EcOLI 1 (A,aa163-213) 
VPPAKILIV-GGGVAGLASAGAAKSMG-A-IVRGFDTRAAALEQFKSLG 
VPPAKVMVI-GAGVAGLAAIGAANSLG-A-IVRAFDTRPEVKEQVQSMG 
GSH HUMAN (FAD) VASYDYLVI-GGGSGGLASARRAAELG-A-RAAVVESHKLGGTCVNVGC 
GLYCERALDP DH PIG ---VKVGVN-GFGRIGRLVTRAAFNSGKVDIVAINDPFIDLHYMVYMFQ 
LIPOAMID DH HUMAN KVPEKMVVI-GAGVIGVELGSVWQRLG-AD-VTAVEFLGHVGGVGIDME 
LIPOAMID DH PIG KVPEKMWI-GAGVIGVELGSVWORLG-AD-VTAVELLGHVGGIGIDME 
LDH PIG M VFHNKITW-GVGAVGMACAISIiGKELADEIALVDVMEDKLKGEMMDL 
TH-BOV 2 (aa230-280) PLEVDVKES-GEGQGGYAKEMSKEFIEAEMKLFALQCKEVDILISTALI 
TH-ECOLI 2 (A,aa211-221) FLELDFKEEAGSGD-GYAKVMSDAFIKAEMELFAAQAKEVDIIVTTALI 
ENZYME 
TH-BOV 3 (aa880-937) 
TH-ECOLI 3 (B, aa305-362) 
GSH HUMAN 
GSH ECOLI 
THIORED RED ECOLI 
TRYPT RED 
MERC RED SHIG 
MICR MONO RABBIT 
TH-BOV 4 (aa994-1043) 
TH-ECOLI 4 (B,aa419-462) 
A. NAD (H) -binding sites 
f tt 
B. NADP (H) -binding sites 
EANSIIITPGYGLCAAKAQYPIADLVKMLSEQGKKVRFGIHPVAG-~PGQLNVLLAEA 
NSHSVIITPGYGMAVAQAQYPVAEITEKLRARGINVRFGIHPVAG-RLGGHMNVLLAEA 
ELPGRSVIVGAGYIAVEM----AGILSAL---GSKTSLMIRHDKVLRSFDSMISTNCTE 
ALPERVAWGAGYIAVEL----AGVINGL---GAKTHLFVRKHAPLRSFDPMISETLVE 
YRNQKVAVIGGGNTAVEE----ALYLSN-----IASEVHLIHRRDGF~EKILIKRLMDK 
EPPRRVLTVGGGFISVEF----AGIFNAYKPVGGKVTLCYRNNPILRGFDYTLRQELTK 
TIPKRLAVIGSSWALEL----AQAFARL---GAKVTILARSTLFFRE-DPAIGEAVTA 
FKDKRVLWGMGNSGTDI----AVEASHV---AKKVFLST 
QVIVMKRSLGVGYAAVDVPIFYKPNTAMLLGDAKKTCDALQA-KV-RESYQHCOOH 
NVIVFKRSMNTGYAGVQNPLFFKENTHMLFGDAK---ASVDA--ILKALCOOH 
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thetic) groups in H’-TH, the two substrates NAD(H) and 
NADP(H) have to interact directly at least during catalysis. 
Consequently, the NAD(H) and NADP(H) binding sites 
have to be located very closely. Presumably, the latter 
labelling was therefore a result of binding of 8-azido-AMP 
to the NAD(H) site, but because of the close location of 
the NADP(H) site and the nearby reactive Tyr-1006, it 
reacted with this residue. It was later shown by site-specific 
mutagenesis with E. coli H+-TH that the corresponding 
residues cxTyr-226 and /3 Tyr-43 1 are not essential [57]. 
However, the P-subunit of E. coli H+-TH binds immobi- 
lized NAD+ ([63]; Glavas, N.A. and Bragg, P.D., unpub- 
lished data) and it is therefore also possible that, at least in 
E. coli H+-TH, the P-subunit indeed contains an 
NAD(H)-binding site which may be catalytically inactive. 
By using equilibrium binding of radiolabelled sub- 
strates, Hatefi and coworkers showed that sequence(s) 1 
and/or 2 binds NADH and sequence(s) 2 and/or 4 binds 
NADPH at a ratio of 1 mol substrate/dimer [28]. Thus, 
there is now little doubt that the N-terminal half of the 
bovine enzyme (a-subunit of the E. coli H+-TH) harbours 
the NAD(H)-binding site and that the C-terminal half 
( P-subunit of the E. coli H+-TH) harbours the 
NADP(H)-binding site. However, recent multiple align- 
ment analyses of H+-TH indicate that the earlier conclu- 
sions based on covalent labelling of tyrosine residues 
regarding the locations of the active NAD(H) and 
NADP(H) binding sequences in sequences 2 and 4 proba- 
bly are erroneous [24,59]. Table 4 shows an alignment of 
sequence 1 with those of several other nucleotide-depen- 
dent enzymes. As will be discussed in depth in Section 5, 
sequence 1, rather than 2, gives the correctly 3D-predicted 
Table 4 
Sequence comparison of ADP binding of pap folds of category I dinucleotide binding protein 
Source Sequence Reference 
<-PA-> <_-___~B__--_, <-PB-> 
"DE** * n n no. 
194 
ADH (NAD) TCAVFGLGGVGLSVIMGCKAAGAA-RIIGVDI 
22 
LDH (NAD) KITWGVGAVGMACAISILMKDLADEVALVDV 
2 
GPD (NAD) KIGIDGFGRIGRLVLRAALSCGAQ-WAVNDP 
4 
PHBH (FAD) QvAIIGAGPSGLLLGQLLHKI--DwILER 
22 
GRS (FAD) PYLVIGGGSGGLASARRAAELGA--F?AAWES 
167 
FcTH (NAD) KVMVIGAGVAGLAAIGAANSLGA--1VRAFDT 
186 
BTH (NAD) KILIVGGGVAGLASAGAAKSMGA--1VRGFDT 
174 
RrTH (NAD) RVLVFGVGVAGLQAIATAKRLGA--VVMATDV 
665 
EtTH (NAD) KVFVIGAGVAGLQAISTAHGLGA--QVFGHDV 
205 
Jornvall, 1970 [641 
Taylor, 1977 [651 
Davidson et al., 1967 [661 
Weijer et al., 1982 1671 
Krauth-Sieghel et al. 
Ahmad et al., 1992 
1982 1681 
[511 
Holmberg et al., 1994 1531 
Williams et al. 1994 [291 
Kramer et al., 1993 t261 
EaTH (NAD) KVFVIGAGVAGLQAISTAHGLGA--QVFGHDV Vermeulen et al., 1993 
fian** * tI a n !I . 
<-PA-> <_____aB_-___> <-PB-> 
[251 
The fingerprint amino acids in the fold are indicated at the bottom. Underlined residues have deviating properties. ” 0 ” indicates hydrophobic 
residues,” * ” the dinucleotide GXCXXG consensus sequence, ^polar residues, and 0 acidic residues. ADH represents alcohol dehydrogenase; LDH, 
lactate dehydrogenase: GPD, glyceraldehyde-3-phosphate dehydrogenase; PHBH, p-hydroxybenzoate hydroxylase; GRS. glutathione reductase; EcTH, E. 
co/i transhydrogenase; BTH, bovine transhydrogenase; RrTH, Rh. rubrum; EtTH, Etenrlla transhydrogenase; EaTH, E. acendina transhydrogenase. 
Numbers within brackets indicate reference numbers (Refs. [25,26,29,5 I ,53,64-681). 
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Fig. 3. A representation of the NAD binding domain of E. co/i H+-TH. The picture was prepared using the MOLSCRIPT package 1741, and is a 
computer-derived model based on comparisons with fingerprint sequences of homologues NAD/FAD-dependent enzymes with known 3D structures. The 
nomenclature is that used by Eklund and Branden [80]. The P-strands are shown as blue shaded arrows and the cu-helices as yellow shaded ribbons. The 
loops extending from PA and /3D which create the switchpoint are shown in red. The NAD substrate molecule is displayed as sticks, and residues 
involved in interactions with NAD(H) are shown with ball and sticks. From Ref. [59]. 
pap-fold of the NAD(H) site. In this context it must be 
emphasized, however, that the /3aP fold only binds the 
pyrophosphate moiety of the dinucleotide and that a dinu- 
cleotide domain covers approximately 150-200 residues 
[69], which means that e.g both of the sequences 3 and 4 
theoretically may form part of the NADP(H)-binding do- 
main. Nevertheless, judging from other dehydro- 
genases/FAD enzymes, there can only be one pa@-fold 
per dinucleotide site [69], which raises the very interesting 
question; what are the roles of the /3cr@like folds in 
sequences 2 and 4? Since the /?-subunit of E. coli H+-TH 
binds to immobilized NADC ([63]; Glavas, N.A. and 
Bragg, P.D., unpublished data) one possibility is that they 
represent inactive remnants of gene-duplicated nucleotide- 
binding sites in the fusion precursor of this domain. It is 
intriguing that the counterparts of the two reactive ty- 
rosines (Tyr-245 and Tyr-1006) in bovine H+-TH are also 
found in the P-subunit of F,-ATPase as part of a 2-azido- 
ATP and FSBI-reactive site [24]. 
The resolution of the three-dimensional structure of 
F,-ATPase from bovine heart [70] has established the 
coordinates for the @Tyr-345 reacting with 2-azido-ATP 
or FSBI bound at the catalytic site, and for the pTyr-368 
reacting with these agents when they are bound at the 
non-catalytic site [71]. Interestingly, the sequences contain- 
ing the 2-azido-ATP/FSBI-reactive p Tyr-34.5 in F, - 
ATPase and the 8-azido-AMP-reactive /?Tyr-43 1 in E. 
coli H+-TH are similar. However, H+-TH’s do not contain 
the so-called P-loop motif GXXXXGT/S. 
A very interesting development was the recent demon- 
stration that the sequence of alanine dehydrogenase from 
Bacillus is homologous with that of the N-terminal half of 
the bovine H+-TH and the a-subunit of E. coli H+-TH 
[22,23]. Alanine dehydrogenase catalyses the reversible 
reductive amination of pyruvate to alanine. However, the 
soluble CY l-subunit of Rhodospirillum rubrum does not 
function as an alanine dehydrogenase [22]. There is only 
one NAD(H)-binding site and therefore one @p-fold in 
alanine dehydrogenase, which is almost identical with that 
located in sequence 1. Delforge et al. [23] speculated that a 
putative H+-TH of Mycobacterium tuberculosis may have 
a role in the virulence mechanism of this important bac- 
terium. 
The consensus sequence GXGXXG for an NAD(P)-bi- 
EcTH 
BTH 
RrTH 
EtTH 
EaTH 
EcTH 
BTH 
RrTH 
EtTH 
EaTH 
EcTH 
BTH 
RrTH 
EtTH 
EaTH 
EcTH 
BTH 
RrTH 
EtTH 
EaTH 
aaa 
<----_----a---___> <___-- 
130 
LSSMANIAGY RAIVEAAHEF GRFFTGQITA AGKVPPAW YIGAGVA& 
149 198 
__________ K-V-L--NH_ _____----_ ________IL IV-G----__ 
137 186 
_--QS-L__- --TJIDG_Y_- A-A-P~_- _-T-_--R-L -F-V-----Q 
628 677 
K-A-QGLQ-- --VI--FNAL PKLSKASIS- --R-EA---F ---------Q 
168 217 
K;A-QGLQ;; -;VI--FNAL PKLSKASIS; ;;R;EA;--F --;-;;;;;Q 
aaaaa -#-JB----> P <-PB-> 
aaaaaaaaa <---UC----> <-PC> <-- 
180 229 
AIGA@JSLGA Im_FDTRPE VKEQVQSMGA EFLELD..FKEE AGSGDGYAKV 
199 248 
SA---K-M__ -__(-.___~ AL_-FK-L-_ _p__V_..L--S GEGQG---_E 
187 238 
--AT-KR--- V-M-T-V-AA T----E-L-G K-ITV-DEAMKT -ETAG----E 
678 727 
--ST-HG--- Q-FGH-V-SA TR-E-E-C-G K-IG-..RMG-- GEVLG---RE 
218 267 
--ST-HG-;; Q;FGH;V;SA TR;E-E;C;G K-IG-..RMG-- -EVLG;;;RE 
aaaaaaaaaaaaa aaaaaaa __aj------------> <P~g!?y <---(XE--> < 
230 279 
MSDAFIKAEM ELFAAQAKEV DIIVTTBLIP GKPAPKLITR EMVDSMmGS 
249 298 
__KE--E--- ----Q-c--- --LIS____- --K__I_FNK --IE--_E-- 
239 288 
-GEE-R-KQA -AVLKELVKT --AI-_____ _____V___E -_-TK__P-- 
728 777 
-G--YQR-QR -MI-NTI-HC -WIG--A-H -R-S----S- D-LR---P-- 
268 317 
;G--YQR-QR ;-I-NTI-HC ;WIC;;A;H ;--S;-;-S- D;LR-;-P;; 
2;J3E-> 319 
VIVDLAAQN..... ..G GNCEYTVPGE IFTTENGVKV IGYTDLPGRL 
299 337 
-V-----EA.......- --F-T-K--- LY.VHK-ITH -------SRM 
289 321 
--I---VEA.......- ---PLSE--K -.WKH---I V-H-NV-SRV 
778 832 
-W---TEFGDVRSGW- --V-VSPKDD QIWD.--T- --RRRIETRM 
218 263 
;--;I;TEFGDTRSGW; ;;V-VSPKDD QWVD.;IT- -;RKRIETRM 
Fig. 4. Alignment of amino acid sequences of tranjhydrogenasea from five different sources. Residues identical to the corresponding amino acids in the E. 
co/i sequence are represented as dashes. Dots indicate gaps. Underlined residues are structurally important or involved in NAD(H) binding. Stars denote 
positions with totally conserved residues. The prediction of cu.helices and /.kheets are shown within arrows. 
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nding site can vary and there are a number of different 
structural requirements for an NAD-site and an NADP-site 
1591. Both the spacer ‘X’ can be extended to, for example, 
GXXGXXG or GXXXGXXG [72], and especially the first 
and the last glycine can be exchanged for, e.g., alanine, or 
asparagine in the case of the first glycine [62,73]. In 
contrast to the NAD(H)-binding domain, the putative 
NADP(H)-binding domain in sequence region 3 shows 
fewer conserved/identical residues with other NADP-de- 
pendent enzymes and reductases. This is simply because 
considerably fewer primary structures of this type have 
been solved. Despite this limitation sequence region 3 
fulfils all requirements for an NADP(H)-site, i.e., the 
consensus sequence of the pap-fold is GXGXXA/V 
instead of GXGXXG, and it contains the two His-920 and 
Arg-925 residues downstream the GXGXXA/V sequence 
of the bovine enzyme stabilizing the acidic 2’-phosphate 
moiety [24]. Although sequence region 4 has NxGxxG, 
which is acceptable for an NAD(P)-binding site, it lacks at 
least two of the essential residues downstream from the 
NXGXXG [24]. 
Using the more flexible definition of an NAD(P)-bind- 
ing site, e.g., GXXXGXXG, there is in fact a third possi- 
ble binding sequence, sequence 3b, in the region 719-826 
(bovine H+-TH), with the sequence GALIGSSG. How- 
ever, again, this sequence lacks the essential basic residues 
downstream stabilizing the 2’-phosphate moiety. Just as in 
the case with sequences 1 and 2, the possible role(s), if 
any, of the sequences 3b and 4 remains to be clarified. 
As will be discussed in Section 6, the predicted trans- 
membrane sequences are apparently not homologues with 
those of other known membrane protein sequences. 
5. The extended Pa/?-folds of the catalytic NAD(H) 
and NADP(H) sites 
5. I. The NAD(H) binding site 
To elucidate the mechanism for the coupling between 
NADPH production and proton gradient utilization at the 
molecular level, structural knowledge is essential. Also, 
the more structural information available the greater is the 
opportunity to fine tune further experimental work, i.e., 
mutagenesis studies. Therefore, a model of the NAD bind- 
ing site with E. co/i H+-TH as an example has been 
constructed [59]. The result of the three-dimensional pre- 
diction is presented in Fig. 3 prepared with the 
MOLSCRIPT [74] package. Structurally important residues 
and amino acids involved in substrate binding that are 
described in this section can be localized in Fig. 4. The 
following methods have been used for prediction: the 
primary structures of the H+-TH’s from E. coli [l I], 
bovine [ 12,531, Rh. rubrum [29,30], and the putative trans- 
hydrogenases from E. tenella [26] and E. acertiulina [25] 
were aligned, and conserved features were compared to 
sequences of structurally solved enzymes that use NAD as 
coenzyme or substrate; hydrophilicity profiles according to 
Kyte and Doolittle [75] and secondary structure predictions 
according to Chou and Fasman [76], Garnier et al. [77] and 
mainly PHD [78] aided in the assignment of the different 
secondary structure elements in the open twisted cr/p 
structure. 
This study supports previous suggestions that the 
monomeric transhydrogenase contains one NAD binding 
site which is located in the soluble part of the a-subunit in 
E. coli transhydrogenase [24]. Each of the five transhydro- 
genases includes one stretch that exactly correlates to the 
Wierenga fingerprint [62,79] for ADP-binding Pa/3 folds 
of category I dinucleotide binding proteins. In the E. coli 
enzyme, residues (Y 167 to (Y 196 correspond to this partic- 
ular fold. The region contains the GXGXXG consensus 
sequence (cy 172 to (Y 177) located in the N-terminal end of 
the dinucleotide binding helix cr B. The first glycine pro- 
vides for a tight turn between PA and aB, the second 
glycine is sterically important for the close binding of the 
pyrophosphate bridge in NAD to aB, and the third glycine 
determines the packing of (YB to the /3 core [62]. The first 
two glycines in E. coli transhydrogenase have been ex- 
changed by the method of site directed mutagenesis. The 
aG172E mutant yielded a catalytically inactive enzyme as 
did the aG174C mutant [59]. However, the cwG 174s was 
found to retain 30% catalytic activity and the aG174A 
mutant was almost as active as the wild type enzyme [59]. 
The observation that five out of seven 6-phosphogluconate 
dehydrogenases in the Swissprot protein database contain 
an alanine in the equivalent second glycine position is 
supportive of the partial activities found in the latter two 
mutants. 
An acidic residue located in the end of @B is almost 
invariably present in enzymes binding NAD. The role of 
this residue is to, via its carboxyl group, form one or two 
hydrogen bonds to one or both hydroxyl groups in the 
adenosine ribose moiety. In the E. coli enzyme this amino 
acid corresponds to Asp-195. A hydrophobic residue com- 
monly follows the conserved acidic amino acid, and its 
function is to create half of a hydrophobic sandwich [80] in 
which the adenine part of the dinucleotide is embedded. 
aThr- 196 is the only candidate for this function. The 
second half of the adenine sandwich is provided for by a 
residue located in the C- terminal end of PD. 
The positions of helix aC and strand PC were deduced 
from the finding of a striking similarity between trans- 
hydrogenases and 29 alcohol dehydrogenases, three out of 
four formate dehydrogenases, and six sorbitol dehydro- 
genases extracted from the Swissprot database [59]. 
Namely, the thirteenth residue from the conserved acidic 
residue in the end of /3 B happens to be a glycine in all 
these sequences. The crystal structure of alcohol dehydro- 
genase from horse liver reveals that the function of this 
glycine is to terminate aC and initiate the turn to PC. 
Presumably, the situation is the same for transhydro- 
genases. The assignment of residues (Y 198 to LY 207 to oC 
is also strongly supported by PHD secondary structure 
predictions for equivalent regions in all transhydrogenases. 
aD, including residues (Y 226 to (~244, was mainly 
assigned based on secondary structure predictions, since 
this part varies quite extensively amongst the different 
NAD binding enzymes [59]. On the other hand, PD, the 
strand which together with PA create the switchpoint into 
which the dinucleotide is fitted, contains certain character- 
istic features: a charged residue at the N-terminal end of 
/3D is prevalent; at least five of the six following residues 
are mainly hydrophobic and and are suggested to adapt 
almost invariably P-strand structure, and the sixth of these 
residues forms the second half of the adenine sandwich. 
The stretch (~250 to (Y 256 and corresponding regions in 
the four other transhydrogenases contain all the appropri- 
ate features (Fig. 4). Accordingly, (uAla-256 is situated 
such as to complete the sandwich around the adenine 
moiety. The role of the highly conserved charged residue 
in the beginning of PD seems to be to establish an 
interaction, presumably often as a salt bridge, with a 
residue in the neighbouring /3E for proper alignment of 
the two P-strands. Indeed, the transhydrogenases contain a 
totally conserved lysine just after a predicted o-helix and a 
couple of positions before a hydrophobic stretch predicted 
as a P-strand. This pattern is also observed in many 
dehydrogenases, such as formate, malate, and glyceralde- 
hyde-3-phosphate dehydrogenase. It is noteworthy that an 
additional conserved feature is the presence of a glycine 
immediately preceding or initiating DE. The pocket pro- 
vided for the nicotinamide part of the dinucleotide is partly 
created by hydrophobic residues extending from aA and 
p E. Here, aPhe-152 and aLeu-284 are tentatively sug- 
gested to form this pocket. 
5.2. The NADP(H) binding site 
According to experimental evidence, the soluble C- 
terminal domain of the P-subunit in E. coli H+-TH ac- 
commodates the NADP(H) binding site [ 14- 19,281 This 
part of the enzyme is particularly intriguing for two rea- 
sons. First of all, multiple sequence analysis of transhydro- 
genases from E. coli, bovine, R. rubrum and E. tenella 
reveals a 35% identity in this region compared to 26% in 
the full length protein. A spontaneous reflection about this 
fact is that the structure and function of this domain is 
especially important for the mechanism of the enzyme. 
Second, binding of the NADP(H) substrate is accompanied 
by a conformational change, as concluded from the varia- 
tion in tryptic digestion patterns observed in the presence 
or absence of NADP(H) [63]. The mechanistic implication 
of this structural change has not been fully determined, but 
it has been suggested that the movement is coupled to 
proton translocation. However, the elucidation of the 
molecular details by which this occurs requires knowledge 
about the three dimensional structure. 
Sequence comparisons with some NADP(H)-dependent 
enzymes have been presented by Hu et al. [24]. In addition 
to the proposal of a catalytic NADP(H) binding site cen- 
tered around the dinucleotide binding consensus-like 
residues p 3 14-/33 19, they suggested the presence of a 
noncatalytic dinucleotide site at p428-p433. The latter 
site is unlikely to bind NADP(H) for the following rea- 
sons: a little over 200 residues in the soluble C-terminal 
domain can hardly compose two dinucleotide binding sites; 
no conserved positive residues, that are commonly found 
to stabilize the 2’ phosphate group, are present down- 
stream of the ill-defined and poorly conserved consensus 
sequence. The proposed catalytic site in transhydrogenase, 
however, show considerable similarities with those of other 
NADP-binding enzymes [24]. This indicates a resemblance 
in the tertiary folding arrangement. A nomenclature analo- 
gous to the one presented for the NAD(H) domain will be 
used in the following discussion. The alanine in the 
GXGXXA consensus sequence for NADP(H)-dependent 
enzymes that adopt a compact dinucleotide /3cvp fold [73], 
such as glutathione, thioredoxin and trypanothione reduc- 
tases, corresponds to valine in all transhydrogenases except 
for the bovine enzyme, where this residue is an alanine. 
The former valine, p Val-3 19 in E. coli H+-TH, can be 
replaced with glycine without any change in catalytic or 
proton pumping activity (Ahmad, S., Glavas, N.A. and 
Bragg, P.D., unpublished data). Further differences include 
a longer cuB helix which presumably comprises a bend at 
residues p323-p325. There are three major reasons for 
believing that the NADP(H) domain in transhydrogenases 
adopts a conformation that can be compared to the reduc- 
tases mentioned above. First, the similarity in the consen- 
sus sequence is considerable and includes the two con- 
served glycine residues. Second, the PHD method yields 
strong P-strand secondary predictions at residues p309- 
p3 1 1 and /3340-/3344, immediately preceding and suc- 
ceeding cy B, respectively, and corresponding regions in all 
transhydrogenases (except for two residues in the E. tenella 
enzyme). Third, the positions downstream of /3B include 
two conserved positively charged residues separated by 
four amino acids, which could well be responsible for the 
interactions with the 2’ phosphate group in the NADP(H) 
substrate. In addition, the mutations of PGly-314 to Glu, 
Ala, Val and Cys all yielded inactive enzymes incapable of 
performing the NADP(H)-induced conformational change 
[5 11. 
6. Predicted secondary structures of the transmem- 
brane domain 
Following the cloning and sequencing of the DNA for 
E. coli H+-TH [ IO,1 11, the transmembrane domain of this 
enzyme was proposed to involve a 14 a-helix structure 
[ 1 I]. This model was later refined to include 12 cr-helices 
[5 1,631 and a similar model was recently suggested for the 
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Rhodospirillum enzyme [29,30]. The transmembrane do- 
main of the bovine enzyme was proposed to contain 14 
helices [ 12,811. In the discussion below, possible trans- 
membrane helices are numbered according to the 14-helix 
model of Hatefi and co-workers [ 12,8 11, which represents 
the maximal number of transmembrane helices regardless 
of the prediction algorithm applied. Thus, for example, 
helix 14 is denoted 14 even though there are only 12 
helices in a particular model. It is also assumed that all 
proton-translocating transhydrogenases have a common 
membrane structure of the helix bundle type, which is the 
dominating structure for membrane proteins with known 
3D structures (e.g., bacteriorhodopsin). 
Because of the number of restraints the prediction of 
transmembrane regions of membrane proteins is consider- 
ably easier than that of hydrophilic domains. Several pre- 
diction algorithms exist today which partly are based on 
the same assumptions. However, a combination of several 
algorithms has recently proven more efficient in predicting 
transmembrane secondary structures, mainly CY helices, as 
applied to Hf-TH [53]. In the case of the bovine H+-TH 
and E. coli Hf-TH application of the various algorithms 
led to an elimination of 4 and 2 helices from the original 
14 and 12 helix models, respectively, leading to two 10 
helix models [53]. Recently, a novel prediction method 
was published based on weighted propensity values for 
multiply aligned sequences of hydrophobic core and termi- 
nal regions of potential transmembrane helices [85]. The 
latter method gave 12 helices, similar to a 12-helix model 
discussed previously [53] except that helix 14 also was 
extended to contain both helix 13 + 14 (Persson, B., un- 
published data). 
All of the above models are based mainly on the 
following biochemical information: (i) antibodies towards 
the N-terminal and the C-terminal hydrophilic domains as 
well as the peptide corresponding to the sequence positions 
540-554 in bovine H+-TH were all found to bind to the 
enzyme in submitochondrial particles but not in mitoplasts, 
indicating that these peptides are located on the matrix side 
of the membrane [81]; (ii) proteinase K hydrolyzes the 
Ala690-Ala691 bond of bovine H+-TH in mitoblasts but 
not in submitochondrial particles, suggesting that this bond 
is located on the cytosolic side of the membrane [81]; (iii> 
considering the ‘positive-inside rule’ of Von Heijne [82- 
841 the strongly charged loop p 150- 166 (5 positive 
charges) of the E. coli H+-TH (as well as bovine H+-TH) 
is assumed to be located on the cytosolic side. In addition 
to prediction of CY helices, predicted information regarding 
P-sheets, connecting loops and turns have been included in 
the modelling procedure. 
The preferred predicted E. coli H+-TH IO-helix model 
is shown in Fig. 5. In this model the helix numbering used 
in this text follows the original 14-helix bovine model 
(helix numbers in parentheses). The four helices in the 
W 
T 
NH2MSGGLVTAAYI 
V 
LSFIFLIAA 
C A K FLLLIVFV s 
S GLSKHETSR G R 
P a 
R 
OK VE C DT N 
W G K 
COOHN K R F M KLM 
N A 
N 
L 
F R 
” L 
L P DNSLM 
I V F . 
H 
P V G 
D 
A V A 
A G ’ S MLNSYSGWAAAA 
VII VIII 
(9) (10) 
Fig. 5. Predicted membrane LY helices of the E. coii H+ -TH. Circled residues have been subjected to mutagenesis (cf. Table 2). Upper side faces the 
cytoplasm and the lower side faces the periplasmic space. From Ref. [53]. 
a-subunit of the E. coli H’-TH and in the corresponding 
regions of other transhydrogenases, except Rhodospirillum 
rubrum H+-TH, are predicted with a high degree of proba- 
bility. A single hydrophobic helix was predicted in the 
soluble (Y 1 -subunit of Rhodospirillum rubrum H+-TH, but 
this helix is probably not a membrane helix because of the 
homology with the soluble alanine dehydrogenase [29]. In 
the cu2-subunit of Rhodospirillum rubrum Hf-TH three 
helices are strongly predicted and one weakly [29]. In the 
P-subunit of E. coli HI-TH, helix IO with its C-terminal 
on the cytosolic side is very likely because of the pro- 
teinase K cleavage site in the bovine enzyme and the 
assumed distribution of charged residues on the cytosolic 
side. Because of the short loop connecting helix 9 and 10. 
this also means that the periplasmic location of the C- 
terminal of helix 9 is quite certain. The C-terminal location 
of the E. coli sequence corresponding to the antibody-bi- 
nding site of helix 4 in the bovine enzyme, the location of 
the C-terminal of this helix on the cytosolic side, and the 
lack of helix 5 in E. coli H’-TH (this sequence is missing 
in the E. coli enzyme) are certain. Helix I3 is likely to be 
included in an extended helix I2 or 14. This leaves helices 
6 and I I, i.e., the ends of the domain corresponding to the 
P-subunit of E. coli H+-TH as weakly predicted and they 
have therefore been removed. Another uncertainty is the 
sidedness of the N-and C-terminal residues. In analogy 
with the majority of other membrane proteins with reason- 
ably well known topologies, it has generally been assumed 
that these residues are on the cytosolic side [53], despite 
the fact that examples with reverse topologies indeed do 
exist (e.g., Ref. [86]). Comparing the bovine and E. coli 
enzymes. it is in fact likely that the C-terminus of the 
a-subunit and the N-terminal of the P-subunit correspond 
to the sequence in the bovine H+-TH that links these 
domains, and that both termini therefore would be located 
on the same side as the bovine sequence. 
In addition to what already has been deduced from the 
bovine and E. cwli Hf-TH’s structures, the high extent of 
sequence identity in the predicted membrane helices of all 
Hf-TH’s so far sequenced has not provided much new 
information derived from, for example, multiple align- 
ments. From the above information it is therefore obvious 
that, although the structure of transhydrogenases may be 
modelled. the establishment of the true membrane structure 
requires a considerable effort. This is a major future task 
which of course will be carried out in parallel with at- 
tempts to crystallize transhydrogenases. 
7. Assembly of transbydrogenases 
The active forms of both the E. cnli H’-TH and bovine 
H+-TH have been shown to be composed of (Y? & [37] 
and a homodimer [ 12,3.5,87]. respectively. As suggested by 
Jackson and co-workers [29] and others [25,26] transhydro- 
genases are transcribed in different orders and thus proba- 
bly assembled differently. The E. coli and Rhodospirillum 
rubrum enzymes are transcribed in the order CY, /? and (Y I, 
c~2 and p, respectively, from the N-to the C-terminal (cf. 
Fig. I). However, using the nomenclature of the E. coli 
enzyme, the Tenella and Entamneba enzymes are tran- 
scribed in the order /3, cr [25-271. The various domains of 
transhydrogenases may be derived from different genes, 
i.e., using the Rhodospirillum enzyme as the most primi- 
tive enzyme and an ancestor of other transhydrogenases. 
domain cy I would be derived from an alanine dehydro- 
genase or similar protein, the (~2 domain from a second 
protein, and the p domain from a third protein possibly 
involved in carbohydrate transport. The latter is indicated 
by the presence in the Tenella sequence [25] of a consen- 
sus sequence typical of proton-coupled carbohydrate 
(hexose) symporters with a l2-transmembrane a-helix 
structure [88,89]. At least part of the latter protein type 
may represent the proton-translocating function of trans- 
hydrogenases. The more advanced bovine H.+-TH gene 
would have been formed by fusion of the corresponding 
genes of the Rhodospirillum enzyme as they are ordered in 
this organism. whereas in Tenella and Eimeria the order 
has been reversed. 
A systematic study of the assembly of the a-and P-sub- 
units of E. coli H+-TH has been carried out by Bragg and 
coworkers [90.91]. Deletion of the first two a-helices of 
the a-subunit from the N-terminal end abolished activity 
but not assembly although both subunits were loosely 
attached, whereas deletion of the two last helices proved 
that they are essential for both activity and assembly [90]. 
Deletion of one or several of the helices of the P-subunit 
resulted in a correct assembly but with loosely attached 
subunits, and loss of activity [90]. These and other results 
suggest that the a-subunit is first incorporated in the 
membrane and that subsequent the assembly of the P-sub- 
unit requires a correct or nearly correct assembly of the 
a-subunit. In contrast, the assembly of the n-subunit is 
independent of the P-subunit. The last 10 hydrophilic 
amino acids in the C-terminal of the a-subunit proved to 
be important for obtaining an active enzyme but not 
assembly. Presumably, a stretch of positively charged 
residues in the C-terminal of the cr-subunit are important, 
i.e., at least one positive charge is required for assembly of 
the enzyme in a functional form [91]. However, a very 
interesting finding was that mutant enzymes that lacked 
activity but showed a relatively proper assembly, also 
showed a trypsin sensitivity of the P-subunit which is only 
seen in the wild-type enzyme in the presence of NADPH 
[63]. These results suggest that improper assembly of the 
w-subunit leads to a trypsin-sensitive conformational 
change of the P-subunit similar to that normally induced 
by NADPH. As will be discussed in the following sec- 
tions, this also indicates that a particular conformation of 
the a-subunit may trigger a catalytically active conforma- 
tion of the P-subunit, and vice versa, during the 
catalytic/proton pumping cycle. Because of the different 
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order of transcription of the Tenella H+-TH, this type of 
transhydrogenase is probably assembled differently. 
8. Charged residues potentially involved in proton 
pumping 
Acidic and or basic residues located in the membrane 
domain are believed to constitute essential residues in 
proton pumps like F, F,-ATPases [92], bacteriorhodopsin 
[93,94] and pyrophosphatases [95]; membrane acidic 
residues in these proteins are usually reactive to DCCD. 
Charged residues are probably also essential for trans- 
porters like lac-permease [96]. The only conserved acidic 
residues in transhydrogenases are j3Glu82 and @Asp-2 13 
(in E. coli Hf-TH) located close to the predicted helices 9 
and 12, respectively (cf. Fig. 5). However, these residues 
were recently shown by site-specific mutagenesis not to be 
essential [53], and they are apparently not modified by 
DCCD. In contrast to F,F,-ATPases [92] and bacterio- 
rhodopsin [93,94], DCCD-reactive residues in E. coli H+- 
TH are located in the hydrophilic NAD(H)-binding domain 
and have been identified as aAsp-232, CXGIU-238 and 
CXGIU-240. These residues have also been replaced by 
site-specific mutagenesis and found not to be essential 
[S8]. There are also DCCD-reactive residues in the P-sub- 
unit of E. coli H+-TH [58], but these have not yet been 
identified. Indeed, in E. coli Hf-TH, DCCD apparently 
labels the P-subunit more than the corresponding region of 
the bovine H+-TH (N.A. Glavas and P.D. Bragg, unpub- 
lished data), and in R. rubrum H+-TH the main DCCD-re- 
active residues are located in the P-subunit [97]. 
Regardless of prediction algorithms used, the only posi- 
tively charged residues located in a predicted membrane 
a-helix are /3 His-91 and p His-161. In fact, a more re- 
fined prediction [53] suggests that only p His-91 is located 
in a transmembrane helix, namely helix 9 (cf. Fig. 5). 
Mutagenesis of these residues showed that p His-161 is 
not essential, whereas p His-91 is essential for both cat- 
alytic and proton-pumping activity [53]. Thus, the mem- 
brane domain of transhydrogenases only contains a single 
essential positive residue but no acidic residues, which 
makes transhydrogenases unique among proton pumps. 
Fig. 6 shows a model of helix 9 where /? His-9 1 is located 
close to the middle of the helix. Interestingly, the trans- 
verse surface of helix where p His-9 1 is located is indeed 
conserved in all transhydrogenases and contains mostly 
smaller hydrophobic residues, which suggests that this 
surface has an important function. One of the relevant 
questions that can be asked in this context is what other 
residues the @His-91 would interact with as part of a 
potential proton wire. Thus, again assuming a helix bundle 
structure, the only conceivable but hypothetical proton-car- 
rying structure may be bound water molecules. 
In addition to other residues, histidine(s) has previously 
been proposed to be involved in proton transport catalyzed 
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Fig. 6. A predicted model of helix 9 of the E. coli H+-TH 
by lac permease [96,98,99], in the photosynthetic reaction 
centre [loo], and in the response of a Na+/H+ antiporter 
of E. coli to pH [loll. It was recently found that His-326 
of the glutamate transporter from rat brain is the only 
charged membrane residue and this residue was shown by 
site-specific mutagenesis to be essential for transport [ 1021. 
His-326 is also conserved in the sodium-dependent trans- 
porter of certain neutral amino acids like serine, threonine 
and alanine, which also belongs to the glutamate trans- 
porter family [ 103,104]. In addition to the key role of 
histidines in these transport systems, the fact that an 
alanine transporter is included in this family is of obvious 
interest because of the similarity between the a-subunit of 
E. coli H+-TH (and the corresponding domains of other 
transhydrogenases) and alanine dehydrogenase from Bacil- 
lus (cf. Sections 4 and 7). 
9. Mechanism of redox-driven proton pumping 
Several hypothetical mechanisms for proton-pumping 
catalyzed by transhydrogenases have been proposed in the 
past which have been amply reviewed [ 14- 191. Because of 
the fact that the difference in free energy between the 
substrates and products is negligible, all of these mecha- 
nisms involve substrate-induced conformational changes 
which are converted into a vectorial proton translocation. 
The extent of this translocation is a function of the sub- 
strate/product ratio and the number of protons translo- 
cated/product formed (cf. Section 2). 
A role of a redox-active dithiol involving cysteine 
residues suggested previously to be involved in transhydro- 
genation/proton pumping [ 18,331 has been eliminated since 
the only conserved cysteine in transhydrogenases ( PCys- 
260 in E. coli H+-TH) is not essential as demonstrated by 
site-specific mutagenesis [53]. Also, the 2’-OH group of 
the ribose moiety of NAD(H) is probably not involved. 
since 2’-deoxy-NADH indeed does function as a substrate. 
although with a considerably lower affinity [59]. 
An interesting aspect of the coupling mechanism is the 
interaction between the NAD(H) and NADP(H)-binding 
domains of transhydrogenases. As represented by the E. 
coli H+-TH these domains correspond to the (Y- and 
P-subunits. It was shown in the preceding section that a 
modification of the C-terminal of the a-subunit influenced 
the conformation of the P-subunit. In contrast, the avail- 
ability of specific DCCD-reactive acidic residues in the 
NAD(H)-binding domain is influenced markedly by 
NADP(H) binding to the P-subunit [58]. Thus, these inter- 
actions between the substrate-binding domains are re- 
versible and represent long-range conformational changes 
which may extend over at least 500 amino acid residues. 
changes of the enzyme for its substrates in the presence of 
an electrochemical proton gradient [ 14,16,17] reduction of 
AcPyAD+ by NADH in the presence of NADPH was 
originally suggested to involve bound NADH and/or 
NADP+ [ 1061. The corresponding reactions catalyzed by 
the Rhodobacter cupsulatus H+-TH [97] and the deter- 
gent-dispersed partially purified E. coli H+-TH [ 107,108] 
were also suggested to involve bound NADP(H) (but not 
NADH) and Jackson and co-workers stressed that the 
reactions catalyzed by the bovine enzyme reconstituted in 
liposomes and the detergent-dispersed Rhodobacter capsu- 
lams and E. coli enzymes were different [97,107,108]. 
DCCD was proposed to lead to an inhibition of the rate of 
release of NADP+ and NADPH [97,107,108]. However, 
DCCD did not increase binding of NADPH to the bovine 
enzyme under equilibrium conditions [28]. Moreover, the 
affinity of the bovine H+-TH for AcPyAD+ was markedly 
decreased by the presence of an electrochemical proton 
gradient in reconstituted vesicles, whereas that for NADPH 
was unchanged [106]. Using purified E. coli Hf-TH re- 
constituted together with bacteriorhodopsin, it was recently 
shown that a Ap generated by light led to a strongly 
increased affinity and binding of NADH, whereas the 
corresponding properties for thio-NADP (an analogue of 
NADP+) were unchanged [109]. Thus, there is evidence 
for an alteration of the NAD(H)-binding site of H+-TH 
induced by Ap. 
A substantial contribution to the understanding of the 
coupling mechanism of transhydrogenases was provided 
by the demonstration that NADH may reduce AcPyAD+ 
(an analogue of NAD+) in the presence of NADPH, 
catalyzed by either coupled bovine H+-TH vesicles 
[ 105,106], DCCD-treated purified Rhodobacter capsulatus 
H+-TH [97], or detergent-dispersed partially purified E. 
coli H+-TH at a low pH [107,108]. On the basis of affinity 
Recently, Hutton et al. [ 1071 described a mechanism for 
transhydrogenization which was based on the pronounced 
pH-dependency of the reduction of AcPyAD+ by NADH 
in the presence of NADP(H) and the effect of DCCD on 
this reaction. It was proposed that an acidic group ‘X’ is 
protonated when either NADP+ or NADPH binds to the 
enzyme. In the NADH-enzyme-NADP+ complex ‘X’ is 
exposed on the periplasmic space (outside) with a pK, of 
< 5, whereas in the NAD+-enzyme-NADPH complex ‘X’ 
is exposed on the cytosolic side (inside) with a high pK, 
of 6-7. There are minor differences between this model 
and earlier models proposed by others workers in the field 
[ 14-191. However, a new feature is that protonation of ‘X’ 
is dependent on bound NADP(H) (not NAD(H1) and that 
release of the proton is linked to the dissociation of 
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NADP(H) (not NAD(H)). It is also stressed that the mech- 
anism is fully reversible and that, therefore, the stimulation 
by Ap of the reduction of NADP+ by NADH can be 
explained by the same mechanism. 
The finding that p His-9 1 constitutes the only charged 
and essential residue in the predicted membrane domain of 
transhydrogenases suggests a coupling mechanism where 
this residue undergoes an alternating cycle of rate-limiting 
protonation/deprotonation steps described by Hu et al. 
[ 1091 in Fig. 7. Indeed, p His-91 may be identical to 
residue ‘X’ in the model of Hutton et al. [107] described 
above. In the model of Hu et al. [109], NADH and 
NADP+, or NADf and NADPH, determine on which side 
of the membrane pHis-91 is exposed and also the pK, of 
p His-91. When NAD+ and NADPH are bound it is 
proposed that p His9 1 is directed to the cytosolic side and 
buried in the hydrophobic phase of the membrane thus 
increasing its pK,. When NADH and NADP+ are bound, 
it is proposed the /3 His-9 1 is directed to the periplasmic 
space side and freely accessibly to the bulk solute giving a 
relatively normal pK,. The interaction between 
substrate/product binding and p His-91 is reversible, i.e., 
an extensive protonation of /3 His-9 1 on the periplasmic 
side leads to an increased binding of the substrates NADH 
and NADP+ and a decreased binding of the products 
NAD+ and NADPH, in agreement with the kinetics of the 
enzyme in submitochondrial particles exposed to a Ap 
[ 1 lo]. Indeed, it is proposed that it is the extent of protona- 
tion of /3 His-91 on the periplasmic space side which 
regulates the activity of the enzyme by Ap in the presence 
of NADH and NADP+. DCCD is suggested to block the 
protonation/deprotonation cycle due to the modification 
of a residue in its vicinity or along the remaining proton- 
conducting pathway, in a manner that favours the reduc- 
tion of AcPyAD’ by NADH in the presence of NADPH. 
Possibly, this modification by DCCD leads to a state 
where NADP(H) remains bound to the enzyme. In agree- 
ment with this proposal, the pH dependencies for the 
reduction of AcPyAD+ by NADH supported by NADPH 
is a mirror image of that for proton pumping driven by 
NAD+ plus NADPH [109], the former being active at low 
pH and the latter at high pH, with an intersection of the 
two curves at about pH 5.8. This pH is indeed close to the 
pK, of free histidine. A consequence of the assumed lack 
of a deprotonation at low pH as part of the normal cycle of 
p His-9 1 is that NADP(H) will remain bound to the en- 
zyme, and the kinetics of the reduction of AcPyAD+ by 
NADH supported by NADPH will therefore be a ping-pong 
mechanism typical of reducible enzymes [ 1081; the kinetics 
of the normal transhydrogenase reaction at neutral pH is 
that of a random bi-bi mechanism [ 14,15,17,108,111,112]. 
10. Future perspectives 
This review has attempted to convey the large amount 
of information that now is available about structure-func- 
tion relationships of proton-pumping transhydrogenases, 
and the rate at which this information is increasing. In fact, 
we believe that this class of membrane proteins presently 
constitutes one of the best systems for studying long-range 
conformational changes in ion-transporting membrane pro- 
teins in general, and mechanisms of redox-driven proton 
pumping in particular. With the increase in the number of 
transhydrogenase genes cloned, expressed and charac- 
terized, our knowledge of the intriguing physiological roles 
of these proteins will also increase rapidly. Basic knowl- 
edge about structure-function relationships in proteins is 
ultimately a source of improved human health. Trans- 
hydrogenases may well have a key role in regulating 
essential redox-linked functions in the cell. This remains 
perhaps the most challenging future problem of this inter- 
esting group of proton-pumps. 
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